| Jun 25 |
Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
|
| Jun 13 |
Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
|
| Jun 13 |
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
|
| Jun 12 |
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
|
| Jun 6 |
Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
|
| Jun 6 |
Eli Lilly (LLY) Veteran Anat Ashkenazi to Join Alphabet as CFO
|
| May 31 |
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
|
| May 30 |
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
|
| May 30 |
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
|
| May 29 |
Pleasing Signs As A Number Of Insiders Buy Heron Therapeutics Stock
|
